Autocrine	0	9	O
angiotensin	10	21	B-Gene_or_gene_product
system	22	28	O
regulation	29	39	O
of	40	42	O
bovine	43	49	B-Organism
aortic	50	56	B-Cell
endothelial	57	68	I-Cell
cell	69	73	I-Cell
migration	74	83	O
and	84	87	O
plasminogen	88	99	B-Gene_or_gene_product
activator	100	109	I-Gene_or_gene_product
involves	110	118	O
modulation	119	129	O
of	130	132	O
proto	133	138	O
-	138	139	O
oncogene	139	147	O
pp60c	148	153	B-Gene_or_gene_product
-	153	154	I-Gene_or_gene_product
src	154	157	I-Gene_or_gene_product
expression	158	168	O
.	168	169	O

Rapid	171	176	O
endothelial	177	188	B-Cell
cell	189	193	I-Cell
migration	194	203	O
and	204	207	O
inhibition	208	218	O
of	219	221	O
thrombosis	222	232	O
are	233	236	O
critical	237	245	O
for	246	249	O
the	250	253	O
resolution	254	264	O
of	265	267	O
denudation	268	278	O
injuries	279	287	O
to	288	290	O
the	291	294	O
vessel	295	301	B-Multi-tissue_structure
wall	302	306	I-Multi-tissue_structure
.	306	307	O

Inhibition	308	318	O
of	319	321	O
the	322	325	O
endothelial	326	337	B-Cell
cell	338	342	I-Cell
autocrine	343	352	O
angiotensin	353	364	B-Gene_or_gene_product
system	365	371	O
,	371	372	O
with	373	377	O
either	378	384	O
the	385	388	O
angiotensin	389	400	B-Gene_or_gene_product
-	400	401	I-Gene_or_gene_product
converting	401	411	I-Gene_or_gene_product
enzyme	412	418	I-Gene_or_gene_product
inhibitor	419	428	O
lisinopril	429	439	B-Drug_or_compound
or	440	442	O
the	443	446	O
angiotensin	447	458	B-Gene_or_gene_product
II	459	461	I-Gene_or_gene_product
receptor	462	470	I-Gene_or_gene_product
antagonist	471	481	O
sar1	482	486	B-Gene_or_gene_product
,	486	487	O
ile8	488	492	B-Drug_or_compound
-	492	493	I-Drug_or_compound
angiotensin	493	504	I-Drug_or_compound
II	505	507	I-Drug_or_compound
,	507	508	I-Drug_or_compound
leads	509	514	O
to	515	517	O
increased	518	527	O
endothelial	528	539	B-Cell
cell	540	544	I-Cell
migration	545	554	O
and	555	558	O
urokinase	559	568	B-Gene_or_gene_product
-	568	569	I-Gene_or_gene_product
like	569	573	I-Gene_or_gene_product
plasminogen	574	585	I-Gene_or_gene_product
activator	586	595	I-Gene_or_gene_product
(	596	597	O
u	597	598	B-Gene_or_gene_product
-	598	599	I-Gene_or_gene_product
PA	599	601	I-Gene_or_gene_product
)	601	602	O
activity	603	611	O
(	612	613	O
Bell	613	617	O
,	617	618	O
L	619	620	O
.	620	621	O
,	621	622	O
and	623	626	O
J	627	628	O
.	628	629	O
A	630	631	O
.	631	632	O
Madri	633	638	O
.	638	639	O
1990	640	644	O
.	644	645	O
Am	646	648	O
.	648	649	O
J	650	651	O
.	651	652	O
Pathol	653	659	O
.	659	660	O
137	661	664	O
:	664	665	O
7	665	666	O
-	666	667	O
12	667	669	O
)	669	670	O
.	670	671	O

Inhibition	672	682	O
of	683	685	O
the	686	689	O
autocrine	690	699	O
angiotensin	700	711	B-Gene_or_gene_product
system	712	718	O
with	719	723	O
the	724	727	O
converting	728	738	O
-	738	739	O
enzyme	739	745	O
inhibitor	746	755	O
or	756	758	O
the	759	762	O
receptor	763	771	O
antagonist	772	782	O
also	783	787	O
leads	788	793	O
to	794	796	O
increased	797	806	O
expression	807	817	O
of	818	820	O
the	821	824	O
proto	825	830	O
-	830	831	O
oncogene	831	839	O
c	840	841	B-Gene_or_gene_product
-	841	842	I-Gene_or_gene_product
src	842	845	I-Gene_or_gene_product
:	845	846	O
pp60c	847	852	B-Gene_or_gene_product
-	852	853	I-Gene_or_gene_product
src	853	856	I-Gene_or_gene_product
mRNA	857	861	O
increased	862	871	O
7	872	873	O
-	873	874	O
11	874	876	O
-	876	877	O
fold	877	881	O
,	881	882	O
c	883	884	B-Gene_or_gene_product
-	884	885	I-Gene_or_gene_product
src	885	888	I-Gene_or_gene_product
protein	889	896	O
3	897	898	O
-	898	899	O
fold	899	903	O
,	903	904	O
and	905	908	O
c	909	910	B-Gene_or_gene_product
-	910	911	I-Gene_or_gene_product
src	911	914	I-Gene_or_gene_product
kinase	915	921	O
activity	922	930	O
2	931	932	O
-	932	933	O
3	933	934	O
-	934	935	O
fold	935	939	O
.	939	940	O

Endothelial	941	952	B-Cell
cell	953	957	I-Cell
expression	958	968	O
of	969	971	O
c	972	973	B-Gene_or_gene_product
-	973	974	I-Gene_or_gene_product
src	974	977	I-Gene_or_gene_product
was	978	981	O
constitutively	982	996	O
elevated	997	1005	O
after	1006	1011	O
stable	1012	1018	O
infection	1019	1028	O
with	1029	1033	O
a	1034	1035	O
retroviral	1036	1046	O
vector	1047	1053	O
containing	1054	1064	O
the	1065	1068	O
c	1069	1070	B-Gene_or_gene_product
-	1070	1071	I-Gene_or_gene_product
src	1071	1074	I-Gene_or_gene_product
coding	1075	1081	O
sequence	1082	1090	O
.	1090	1091	O

Constitutively	1092	1106	O
increased	1107	1116	O
c	1117	1118	B-Gene_or_gene_product
-	1118	1119	I-Gene_or_gene_product
src	1119	1122	I-Gene_or_gene_product
kinase	1123	1129	O
activity	1130	1138	O
reconstituted	1139	1152	O
the	1153	1156	O
increases	1157	1166	O
in	1167	1169	O
migration	1170	1179	O
and	1180	1183	O
u	1184	1185	B-Gene_or_gene_product
-	1185	1186	I-Gene_or_gene_product
PA	1186	1188	I-Gene_or_gene_product
observed	1189	1197	O
with	1198	1202	O
angiotensin	1203	1214	B-Gene_or_gene_product
system	1215	1221	O
interruption	1222	1234	O
.	1234	1235	O

Antisera	1236	1244	O
to	1245	1247	O
bovine	1248	1254	B-Organism
u	1255	1256	B-Gene_or_gene_product
-	1256	1257	I-Gene_or_gene_product
PA	1257	1259	I-Gene_or_gene_product
blocked	1260	1267	O
the	1268	1271	O
increase	1272	1280	O
in	1281	1283	O
migration	1284	1293	O
associated	1294	1304	O
with	1305	1309	O
increased	1310	1319	O
c	1320	1321	B-Gene_or_gene_product
-	1321	1322	I-Gene_or_gene_product
src	1322	1325	I-Gene_or_gene_product
expression	1326	1336	O
.	1336	1337	O

These	1338	1343	O
data	1344	1348	O
suggest	1349	1356	O
that	1357	1361	O
increases	1362	1371	O
in	1372	1374	O
endothelial	1375	1386	B-Cell
cell	1387	1391	I-Cell
migration	1392	1401	O
and	1402	1405	O
plasminogen	1406	1417	B-Gene_or_gene_product
activator	1418	1427	I-Gene_or_gene_product
after	1428	1433	O
angiotensin	1434	1445	B-Gene_or_gene_product
system	1446	1452	O
inhibition	1453	1463	O
are	1464	1467	O
at	1468	1470	O
least	1471	1476	O
partially	1477	1486	O
pp60c	1487	1492	B-Gene_or_gene_product
-	1492	1493	I-Gene_or_gene_product
src	1493	1496	I-Gene_or_gene_product
mediated	1497	1505	O
.	1505	1506	O

Elevated	1507	1515	O
c	1516	1517	B-Gene_or_gene_product
-	1517	1518	I-Gene_or_gene_product
src	1518	1521	I-Gene_or_gene_product
expression	1522	1532	O
with	1533	1537	O
angiotensin	1538	1549	B-Gene_or_gene_product
system	1550	1556	O
inhibition	1557	1567	O
may	1568	1571	O
act	1572	1575	O
to	1576	1578	O
enhance	1579	1586	O
intimal	1587	1594	O
wound	1595	1600	O
closure	1601	1608	O
and	1609	1612	O
to	1613	1615	O
reduce	1616	1622	O
luminal	1623	1630	O
thrombogenicity	1631	1646	O
in	1647	1649	O
vivo	1650	1654	O
.	1654	1655	O

